• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Psychiatric Research Institute
  • UAMS Health
  • Jobs
  • Giving
  • Clinical Care
    • AR ConnectNow
      • Frequently Asked Questions
      • Mental Health Resources
      • Substance Abuse Facilities
      • Contact AR ConnectNow
    • Center for Trauma Prevention, Recovery and Innovation
      • About Us
        • Collaborations
        • Our Team
      • In The Media
      • Resources
      • Training & Education
        • Education For The Public
        • Training For Professionals
      • What Is Trauma?
    • Child Study Center
      • Dialectical Behavior Therapy
      • Family Resources
        • Handouts for Parents
        • Books
        • Videos
      • Meet the Team
      • Treatment and Services
    • Interventional Psychiatry
      • Electroconvulsive Therapy
      • Esketamine
      • Ketamine Infusions
    • Neurodiversity Clinic
    • Northwest Arkansas Crisis Stabilization Unit
    • STRIVE
    • The Couples Center
      • Helping Couples Expand Their Love Capacities
      • Interdynamic Couples Therapy
      • SOS for Cabin Fever Couples
      • The Essentials of Sex Therapy
      • 2023 Training Opportunities and Certification Program with Chelsea Wakefield, Ph.D., LCSW
      • 2023 Training Schedule
    • Walker Family Clinic
      • Mental Health Resources
    • Women’s Mental Health Program
    • Center for Addiction Services and Treatment (CAST)
      • Improving Access To Treatment For Opioid Use Disorder
      • MATRIARC
        • Project ECHO
      • Medication and Counseling Treatment
      • Medications To Treat Opioid Use Disorders
      • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
      • Suboxone Treatment Program
      • Subutex Treatment Program
      • What is Buprenorphine?
      • What Is Methadone?
      • What Is Naltrexone?
      • What Is Vivitrol?
      • Drugs and Addiction
      • Opioid Use Disorder
    • Inpatient Units
      • Child Diagnostic Unit
        • Child Diagnostic Unit Videos
      • Women’s Inpatient Unit – 5 North
    • Pulaski County Regional Crisis Stabilization Unit
      • Operation SAVE
    • Neuropsychology
    • Psychiatry Clinic in Fayetteville
  • Education
    • For Current Residents
  • Research
    • Center for Addiction Research
      • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
      • What is Vivitrol?
      • Faculty
        • Alison Oliveto, Ph.D
        • Linda Larson-Prior, Ph.D.
        • Merideth Addicott, Ph.D.
        • Michael Mancino, M.D.
        • Nihit Kumar, M.D.
    • Center for Health Services Research
      • Behavioral Health QUERI
      • Health Services Research and Development Service
      • Rural Outreach Program
        • Rural Outreach Program Team
      • South Central (VISN 16) Mental Illness Research, Education and Clinical Center
      • Center for Health Services Research Faculty and Staff
        • Brandon J. Griffin, Ph.D.
        • Carolyn J. Greene, Ph.D.
        • Christopher Long, Ph.D.
        • Corey Hayes, Pharm.D., Ph.D., MPH
        • Eva Woodward, Ph.D.
        • Jacob Painter, Pharm.D, Ph.D.
        • Leah Tobey, PT, DPT, MBA
        • Marcela Weber, Ph.D.
        • Mary J. Bollinger, MPH, Ph.D.
        • Melissa J. Zielinski, Ph.D.
        • Michael Cucciare, Ph.D.
        • Michael Wilson, M.D., Ph.D., FAAEM, FACEP
        • Prasad R. Padala, M.D., M.S., FACHE
        • Rajinder “Sonia” Singh, Ph.D.
        • Sara J. Landes, Ph.D.
        • Traci Abraham, Ph.D.
        • Angie Waliski, Ph.D.
        • Ellen P. Fischer, Ph.D.
        • Geoffrey M. Curran, Ph.D.
        • Greer Sullivan, M.D., M.S.P.H.
        • Jeffrey M. Pyne, M.D.
        • JoAnn Kirchner, M.D.
        • Joy Reeves Pemberton, Ph.D.
        • Karen Drummond, Ph.D.
        • Kristen M. Viverito, Psy.D.
        • Puru Thapa, M.D., M.P.H.
        • Richard R. Owen, M.D.
        • Teresa Hudson, Pharm.D., Ph.D.
        • Teresa L. Kramer, Ph.D.
      • Postdoctoral Fellowship
        • CeMHOR/HSR&D
        • MIRECC
    • Health and the Legal System (HEALS) Lab
      • Projects in the Health and the Legal System (HEALS) Lab
    • Helen L. Porter and James T. Dyke Brain Imaging Research Center
      • Childhood Trauma Study
      • Directions to BIRC
      • Events
      • MRI Frequently Asked Questions
      • Prospective Collaborators
      • Prospective Participants
      • Prospective Trainees
      • Publications
      • Media
      • Resources
    • Neurocognitive Dynamics Laboratory
      • Current Studies
    • Neurodevelopmental Risk and Resilience Program
    • Research Trials
  • Patients and Visitors
    • Advisory Board
    • Art of the Psychiatric Research Institute
    • Mental Health Resources
    • Mission And Vision Statements
    • Positions at the Psychiatric Research Institute
    • Map and Directions
    • Faculty and Staff
    • Giving
  1. University of Arkansas for Medical Sciences
  2. Psychiatric Research Institute
  3. Clinical Care
  4. Center for Addiction Services and Treatment (CAST)
  5. Opioid Use Disorder

Opioid Use Disorder

Opioids are drugs that work in the body the way opium does. Some are made directly from opium, such as morphine, and codeine, while others are man-made but similar chemically to opium, including the painkillers oxycodone, hydrocodone, and fentanyl, better known by such brand names as Oxycontin, Vicodin, Percocet and Actiq. Heroin is also an opioid.

For many, the decision to begin taking drugs is voluntary: it may have started with medicine that your doctor prescribed for serious pain, or with recreational drug use with prescription pain medications or heroin. Regardless of how you became dependent, once dependence has developed it is considered a disease that requires treatment. And, once a person becomes addicted or dependent on a drug, he or she may find that willpower is no match for the chemical, behavioral, and psychological nature of opioid dependence.

Opioid use disorder has been defined as a long-term brain disease by the World Health Organization and the National Institute on Drug Abuse. It is a treatable medical condition that is caused by changes in the chemistry of the brain that occur as a result of the use of opioids.

A person who shows three or more of the following behaviors over a 12-month period is most likely opioid-dependent:

  • Needing to take more of the drug to get the same effect—or getting a lesser effect from the same amount of drug;
  • Experiencing withdrawal symptoms when not using opioids, or taking other drugs to help relieve withdrawal symptoms;
  • Taking larger amounts of opioids than planned, and for longer periods of time;
  • Persistently wanting to quit, or trying unsuccessfully to quit;
  • Spending a lot of time and effort to obtain, use, and recover from taking opioids;
  • Working less, missing work, or, if unemployed, not seriously looking for a job;
  • Spending less time seeing friends who don’t use opioids; skipping recreational activities;
  • Continuing to use opioids despite negative consequences.
Psychiatric Research Institute LogoPsychiatric Research InstitutePsychiatric Research Institute
Mailing Address: 4224 Shuffield Drive, Little Rock, AR 72205
Phone: (501) 526-8100
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences